Skip to content

Evaluation of efficacy and safety of TCM in treating rheumatic immune diseases based on real-world observation

Evaluation of efficacy and safety of TCM in treating rheumatic immune diseases based on real-world observation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081789
Enrollment
Unknown
Registered
2024-03-12
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic immune disease

Interventions

Case series:No

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Age =18 years old; 2) Diagnosed with rheumatic immune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, Sjogren's syndrome, gouty arthritis, etc.)

Exclusion criteria

Exclusion criteria: Information loss

Design outcomes

Primary

MeasureTime frame
DAS28 score;Disease activity index(SLEDAI-2K);Disease activity score(ASDAS);Disease activity index(ESSDAI);Pain grading in acute phase of gout;erythrocyte sedimentation rate (ESR);C-reactive protein(CRP);Rheumatism related test;

Secondary

MeasureTime frame
Blood routine;visu-alalog scale(VAS);Simple disease activity index(SDAI);Clinical disease activity index(CDAI);Health assessment questionnaire(HAQ);Patient health questionnaire Depression Scale(PHQ-9);Generalized anxiety Rating Scale(GAD-7);General Hospital Anxiety and Depression Scale(HAD);TCM syndrome score;Low disease activity(LLDAS);damage index(SDI);Mitigation definition(DORIS);Bath Ankylosing spondylitis activity index score(BASDAI);Bath Ankylosing spondylitis functional index score(BASFI);Patient reporting index(ESSPRI);Detection of T cell subsets;Immune-related test;Disease outcome;

Countries

China

Contacts

Public ContactGuo Hongtao

The First Affiliated Hospital of Henan University of Chinese Medicine

guoht2009@126.com+86 187 3991 6938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026